Analysis of treated DLBCL-LNs verified significantly increased expression of FRC-associated CCL21, suggesting promotion of a T cell–attracting TME (Supplemental Figure 10G). This evidence concerns the gene CCL21 and diffuse large B-cell lymphoma.